Related Experiment Video
Updated: Aug 7, 2025

07:49
Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
2.5K
Tumor malignancy by genetic transfer between cells forming cell-in-cell structures.
Ruizhi Wang1,2, Hao Zhong1, Chenxi Wang3,4
1Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, China.
Cell Death & Disease
|March 14, 2023
Summary
Cell-in-cell structures (CICs) promote tumor progression by enabling genetic transfer. Derivatives from CICs show increased proliferation, invasiveness, and tumorigenicity, indicating enhanced malignancy.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Cell-in-cell structures (CICs) are unique formations where one cell engulfs another, but their role in cancer is unclear.
- Understanding CICs' impact on tumor progression is crucial for developing new cancer therapies.
Purpose of the Study:
- To investigate the effects of CIC formation on hepatocellular carcinoma progression.
- To explore potential genetic transfer and acquisition of malignant phenotypes through CICs.
Main Methods:
- Utilized genetically marked hepatocellular cancer cell lines to study CIC formation.
- Employed flow cytometry sorting to isolate CIC-derived cells for analysis.
- Performed whole exome sequencing to identify genes involved in CIC-mediated genetic transfer.
- Assessed proliferation, invasiveness, and tumorigenicity in xenograft mouse models.
Main Results:
- CIC derivatives exhibited increased proliferation and invasiveness compared to parental cells.
- CIC clones showed molecular markers of epithelial-mesenchymal transition (EMT), including decreased E-cadherin and increased Vimentin.
- Derivatives displayed significantly enhanced tumorigenicity in vivo.
- Whole exome sequencing revealed potential genes involved in CIC-mediated genetic transfer.
Conclusions:
- CIC formation can facilitate genetic transfer, contributing to genomic instability and enhanced malignancy in tumor cells.
- The study suggests CICs play a role in promoting tumor progression and aggressive phenotypes.
- Targeting CIC formation could be a potential therapeutic strategy for hepatocellular carcinoma.
Related Concept Videos
Cancer
49.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
What is Cancer?
10.9K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.9K

